2015's Top IPOs
- Tantech Holding (TANH) 643.75%
- Global Blood Therapeutics (GBT) 163.50%
- Seres Therapeutics, Inc. (MCRB) 145.89%
- Shake Shack (SHAK) 127.67%
- Inotek (ITEK) 108.33%
- Zynerba Pharmaceuticals (ZYNE) 105.71%
- KemPharm (KMPH) 85.91%
- Code Rebel (CDRB) 84.80%
- ProNAi Therapeutics, Inc. (DNAI) 78.24%
- Chiasma, Inc. (CHMA) 77.81%
On July 1, 2015, the IPO Teladoc, Inc. (NYSE: TDOC) opened for trading at $29.90 after pricing 8,250,000 shares of its common stock at a price to the public of $19.00 per share, above the recently expected range of $15 to $17 per share.
J.P. Morgan Securities LLC and Deutsche Bank Securities Inc. are acting as joint book-running managers for the offering. William Blair & Company, L.L.C., Wells Fargo Securities, LLC and SunTrust Robinson Humphrey, Inc. are acting as co-managers for the offering.
Teladoc is the nation's first and largest telehealth platform, delivering on-demand healthcare anytime, anywhere, via mobile devices, the internet, video and phone.
- Cytokinetics (CYTK) Files to Offer $40M in Common Stock
- Celsion (CLSN) Files $75M Mixed Securities Shelf
- ContraFect (CFRX) Files $100M Mixed Securities Shelf
- MannKind (MNKD) Files Automatic Common Stock, Warrant Shelf
- Great Basin Scientific (GBSN) Announces Recent Conversion of Series E Convertible Preferred Shares
- See More
|8/13/2015||Conifer Holdings||CNFR||3.1 Mil||$10.50||$10.11||-3.71%||BMO Capital Markets, Raymond James|
|8/13/2015||Houlihan Lokey||HLI||10.5 Mil||$21.00||$22.35||6.43%||BofA Merrill Lynch, Goldman, Sachs & Co., UBS Investment Bank,Keefe, Bruyette & Woods, Houlihan Lokey, Sandler O\'Neill + Partners, L.P., JMP Securities|
|8/12/2015||Global Blood Therapeutics||GBT||6 Mil||$20.00||$52.70||163.50%||Morgan Stanley, Goldman Sachs|
|8/6/2015||Aimmune Therapeutics, Inc.||AIMT||10 Mil||$16.00||$22.59||41.19%||BofA Merrill Lynch, Credit Suisse, Piper Jaffray|
|8/6/2015||Planet Fitness||PLNT||13.5 Mil||$16.00||$18.59||16.19%||P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Jefferies LLC, Credit Suisse Securities (USA) LLC.|
|8/5/2015||Zynerba Pharmaceuticals||ZYNE||3 Mil||$14.00||$28.80||105.71%||Jefferies, Piper Jaffray, Canaccord Genuity, Oppenheimer & Co.|
|8/5/2015||Amplify Snack Brands, Inc.||BETR||15 Mil||$18.00||$12.27||-31.83%||Goldman, Sachs & Co., Jefferies, Credit Suisse, SunTrust Robinson Humphrey, William Blair, Piper Jaffray|
|8/5/2015||Sunrun||RUN||17.9 Mil||$14.00||$11.56||-17.43%||Credit Suisse Securities (USA) LLC, Goldman, Sachs & Co., Morgan Stanley & Co. LLC, BofA Merrill Lynch and RBC Capital Markets, LLC, KeyBanc Capital Markets Inc., and SunTrust Robinson Humphrey, Inc.|
|8/4/2015||Intec Pharma Ltd.||NTEC||5.025 Mil||$6.00||$5.67||-5.50%||Maxim Group LLC, Roth Capital Partners|
|7/30/2015||vTv Therapeutics Inc.||VTVT||7.8 Mil||$15.00||$9.32||-37.87%||Piper Jaffray, Stifel, Canaccord Genuity, Janney Montgomery Scott|
|N/A||China Dredging||CLFF||N/A||N/A||Chardan Capital|
|N/A||Greenwich Kahala Aviation Ltd.||GKH||15 Mil||12||FBR Capital Markets, Wells Fargo Securities, Cowen and Company, Raymond James|
|N/A||Clarus Therapeutics||CLRS||5 Mil||11.00-13.00||Piper Jaffray, Wells Fargo Securities|
|N/A||The Aveon Group L.P.||AVO||15.7 Mil||14.00-16.00||J.P. Morgan, Jefferies|
|N/A||Primus Therapeutics, Inc.||PRTH||N/A||N/A||Maxim Group LLC|
|N/A||Lighting Science||LSGC||N/A||N/A||Credit Suisse, J.P. Morgan, Stifel Nicolaus Weisel, Moelis & Co., Piper Jaffray|
|N/A||Inland Western Retail Real Estate Trust, Inc.||IWST||N/A||N/A||Citi, Deutsche Bank Securities, J.P. Morgan, KeyBanc Capital Markets|
|Week of N/A||Global Market Group Limited||GMC||2.8 Mil||11.00-13.00||Deutsche Bank Securities, Piper Jaffray, Cowen and Co., Lazard Capital Markets, Oppenheimer & Co.|
|N/A||Newgistics, Inc||NEWG||N/A||N/A||Stifel Nicolaus Weisel, Piper Jaffray, BB&T Capital Markets, William Blair & Co.|
|N/A||Chesapeake Oilfield Services, Inc.||COS||N/A||N/A||Goldman Sachs, BofA Merrill Lynch|
Blue Buffalo Pet Products (NASDAQ: BUFF) filed $500M IPO with the SEC. The company plans to list under symbol "BUFF" on the NASDAQ.
The offering is being led by JPMorgan and Citigroup, with Barlcys, Deutsche Bank, Morgan Stanley, Wells Fargo and LOYAL3 Securities also listed in support.
Blue Buffalo Pet Products is the fastest growing major pet food company in the United States, selling dog and cat food made with whole meats, fruits and vegetables, and other high-quality, natural ingredients. BLUE is a billion dollar brand based on sales at retail and is the #1 brand in the Wholesome Natural market segment. They currently have approximately 6% share of the overall pet food industry and feed only 2-3% of the 164 million pets in the United States.